Dual vs triple anti-thrombotic therapy for post-PCI patients with atrial fibrillation: Scope of the problem and key challenges
- Discuss and debate the four major trials in the DOAC space for post PCI patients with atrial fibrillation in light of international guidelines
- Review the differences in the study designs and aspirin cut-offs and the implications on the data
- Discuss and analyse the role of aspirin in the treatment of anti-thrombotic post PCI for patients with Atrial Fibrillation and ACS
- Analyse and debate the impact on patient care
This video series was funded by an unrestricted educational service from Boehringer Ingelheim.